PALXOTCSemiconductors & Related DevicesFiscal year ends December 31

Palomino Laboratories Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$14.00−0.32 (-2.23%)

Close on Oct 15, 2026

Market cap: $305.46M
P/E (TTM): –
Dividend yield: –

Palomino Laboratories Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
General & Administrative	2.70	0.01	0.08
Operating Expenses	2.70	0.01	–
Operating Income	-2.70	-0.01	-0.08
Interest Expense	–	0.01	–
Interest & Investment Income	0.00	0.00	–
Net Income incl. Noncontrolling Interests	–	–	0.08
Net Income	-3.16	-0.02	-0.08
EPS (Basic)(per share)	-0.47	-0.01	-0.06
EPS (Diluted)(per share)	-0.47	-0.01	-0.06
Shares Outstanding (Basic, Weighted)(shares)	6.71	1.52	1.54
Shares Outstanding (Diluted, Weighted)(shares)	6.71	1.52	1.54

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -78.3%

Financial strength

Current ratio: 53.12
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 5271.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 14.85
Dividend yield: –